Kim L. R. Brouwer, Pharm.D., Ph.D.

(919) 962-7030

kbrouwer@unc.edu

Kim L.R. Brouwer, Pharm.D., Ph.D., is the William R. Kenan Jr. Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics of the UNC Eshelman School of Pharmacy, associate dean for research and graduate education, and a professor in the curriculum in toxicology.

Daniel Crona, Pharm.D., Ph.D.

(919) 966-4343

crona@email.unc.edu

Daniel Crona, Pharm.D., Ph.D., joined the UNC Eshelman School of Pharmacy in 2015. His translational research program focuses on how genetic variations can lead to differences in the pharmacokinetics and pharmacodynamics of therapeutic treatments used in oncology, and how inter-individual differences in clinical pharmacology measures can affect survival and drug toxicity phenotypes.

Amber Frick, Pharm.D., Ph.D.

(919) 962-5495

adfrick@email.unc.edu

Amber Frick, Pharm.D., Ph.D., is a clinical assistant professor with the Division of Pharmacotherapy and Experimental Therapeutics and faculty fellow in CIPhER. Her main responsibilities at the School are to develop an expertise in the implementation and assessment of new approaches to and best practices in teaching while also taking part in collaborative teaching activities.

Craig Lee, Pharm.D., Ph.D.

(919) 843-7673

craig_lee@unc.edu

Craig Lee, Pharm.D, Ph.D. is an associate professor in the Division of Pharmacotherapy and Experimental Therapeutics. His research focuses on cytochrome P450 metabolism, cardiovascular experimental therapeutics, and precision medicine/pharmacogenomics.

Herb Patterson, Pharm.D.

(919) 962-0072

hpatterson@unc.edu

Herb Patterson, Pharm.D., is a professor and the executive vice chair of the Division of Pharmacotherapy and Experimental Therapeutics and a research professor of medicine at the University of North Carolina at Chapel Hill. His clinical research focuses drugs used in heart failure.

Amber Proctor, Pharm.D.

(919) 966-4882

Amber.Proctor@unchealth.unc.edu

Amber Proctor, Pharm.D., joined the UNC Eshelman School of Pharmacy as a clinical assistant professor in the Division of Pharmacotherapy and Experimental Therapy. Proctor’s appointment is cofunded by UNC Hospitals, where she serves as a clinical oncology specialist in thoracic oncology.

Paul Watkins, M.D.

(919) 226-3140

pwatkins@email.unc.edu

Paul Watkins, M.D., is director of the Institute for Drug Safety Sciences at the UNC Eshelman School of Pharmacy and the Howard Q. Ferguson Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics.

Tim Wiltshire, Ph.D.

(919) 843-5820

timw@unc.edu

Tim Wiltshire, Ph.D., is an associate professor in the Division of Pharmacotherapy and Experimental Therapeutics and Director of the UNC Center for Pharmacogenomics and Individualized Therapy. The major focus of his laboratory and CPIT is to take the pharmacogenetic knowledge we already have and develop approaches for that information to be used effectively in clinical practice.

William Zamboni, Pharm.D., Ph.D.

(919) 843-6665

zamboni@email.unc.edu

William Zamboni, Pharm.D., Ph.D., is an associate professor in the Division of Pharmacotherapy and Experimental Therapeutics and UNC Lineberger Comprehensive Cancer Center. He is the director of UNC GLP Bioanalytical Facility and the director of the Translational Oncology and Nanoparticle Drug Development Initiative (TOND2I) Lab. His research interests focus on the application of pharmacokinetic, pharmacodynamic, and pharmacogenetic principles in the optimization of the chemotherapeutic treatment of cancer.